Moreover, the broad distribution of branaplam in the CNS enables HTT protein reduction throughout the brain, including the cortex and striatum, key brain regions in the neuropathology of HD, as well as any impacted peripheral tissues. This evidence concerns the gene HTT and Huntington disease.